Rx revu investor_v4

13
The Institute for Cost-Effective Medicine rev. 4.22.13

Transcript of Rx revu investor_v4

Page 1: Rx revu investor_v4

The Institute for Cost-Effective Medicine

rev. 4.22.13

Page 2: Rx revu investor_v4

Kevin O’Brien, MDExecutive Director

Physician with 25 years of clinical experience. In the 90s Dr. O’Brien created several disease management programs for health plans (Kaiser Permanente, Anthem, Humana, Prudential, and others). Medical Director of one of the nation’s largest medical education companies, with the responsibility of developing physician and patient education programs, and doing focus interviews with hundreds of physicians and patients regarding prescription medicine preferences.

Carm HuntressBusiness Development

Product development expert and strategic leader with over 15 years experience in startups and midsized companies. Broad skills across numerous disciplines include: product development, web marketing, strategic planning, early stage products, and budgeting. Carm’s technical background combined with his ability to manage teams give him the ability to create robust products that are highly successful and quickly adopted by end-users.

Daniel CaronMarketing Officer

A programmer and marketer, Dan has successfully launched three 7 figure consumer products, the highest grossing 3.5 million in 24 hours. Dan has since gone on to develop several highly effective marketing tactics, derived from his research into neuroscience and on the human brain. Has built several multi-million dollar Internet Businesses, is a frequent speaker, and continues to refine his ability to generate sales and drive adoption for his online businesses.

Introduction – RxRevu Team

Page 3: Rx revu investor_v4

Problem

NO TIME for Doctors to address the cost of medications

Medication COSTS ARE RISING 10% year over year

LACK OF TRANSPARENCY around cost effective alternatives

Page 4: Rx revu investor_v4

The Prescription Drug Market

• 150M Americans on medications • 25% of 18-39 on two or more• 25% of seniors on five or more

• $300 billion spent annually • 4.02 billion prescriptions in 2011

• 5200 medications on the market

Page 5: Rx revu investor_v4

Prescription Drugs and Cost

• $36B in overspending on medications• Due to costly prescribing by physicians

• Insufficient information• 47% of doctors talk about costs• 35% of patients don’t ask about costs

• 10% yr-over-yr cost increases until 2020• No Transparency

• Even though the data is available

Page 6: Rx revu investor_v4

RxRevu Solution

Insurance Plans

Medication Data

Retail Costs

Research on Efficacy(3 yrs of research)

Medication Cost Alternatives Report

RxRevuChoice

Algorithm

Page 7: Rx revu investor_v4

Report Benefits

• Displays members current medications • Clearly shows alternatives and cost savings• Includes efficacy information for doctors• Member brings to next doctors visit• Delivery Options:

• By mail or email• Automated report generation (seniors)• Offered directly through website

(white labeled)• API• Mobile

Page 10: Rx revu investor_v4

Target Markets

• Health Plans• Reduces pharma costs• Improves communication

• Self Insured Companies • Lowers claims and insurance costs

• Service Providers• Value-add to existing software• Improves physician knowledge

• Patients/Physicians• Lowers medication costs• Improves adherence• Proactive tool for cost savings

Page 11: Rx revu investor_v4

Current Milestones

• Research completed• Launched website• Landed 4 customers and 2 pilots

in less than 3 months• Built Team• Automating the process to scale

business

Page 12: Rx revu investor_v4

Current Objectives

• Complete Trials• Show definitive RIO with members at scale

• Team Building• Application Developer• Sales/Marketing

• Seek funding to automate process and scale• 300k for 12-18 months of operational coverage

Page 13: Rx revu investor_v4

Next Steps

Comments, Questions, Next Steps…